Clinical trials
Phase 2/3 Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Monash University | 5 |
| Children's Oncology Group | 2 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2 |
| St. Jude Children's Research Hospital | 2 |
| AHS Cancer Control Alberta | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Cancer Research UK | 1 |
| Children's Cancer Group, China | 1 |
| Erasme University Hospital | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 27 |
| Leukemia | 11 |
| Neoplasms | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Infections | 5 |
| Myelodysplastic Syndromes | 5 |
| Neoplasms, Plasma Cell | 5 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Graft vs Host Disease | 3 |
Trials
Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.